Pharmacological Evaluation of Antifungal in Chronic Pulmonary Aspergillosis
NCT05064605 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-06-28
Summary
At present, pulmonary diffusion and target antifungal concentrations for APC in patients with sarcoidosis or chronic obstructive pulmonary disease (COPD) are unknown.
Conditions
- Chronic Respiratory Disease
- Chronic Pulmonary Aspergillosis
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Yurdagül Yuzunhan, MD, PhD · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-01
- Primary Completion
- 2022-10-01
- Completion
- 2024-10-01
Countries
- France
Study Locations
More Related Trials
-
Prospective Cohort Study of Molecular Mechanism of Lower Respiratory Tract Microbes in Patients With AECOPD
NCT04259736 ·Status: UNKNOWN
-
Study of Microbiological Diversity in Exhaled Air in COPD and Free of COPD
NCT05437198 ·Status: RECRUITING
-
Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific
NCT03151395 ·Status: COMPLETED ·Phase: NA
-
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
NCT06885905 ·Status: RECRUITING
-
Diagnostic Value of Sputum Cytology in Asthma-COPD Overlap
NCT04056364 ·Status: UNKNOWN
-
Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis
NCT07313904 ·Status: RECRUITING
-
Allergic Bronchopulmonary Aspergillosis Prescreening Study
NCT05903612 ·Status: WITHDRAWN
-
Blood Eosinophil Measurements in Patients With Chronic Obstructive Pulmonary Disease
NCT03853642 ·Status: COMPLETED
-
Identification of Microbiome and Metabolome of Bronchiectasis in Chinese Population.
NCT04490447 ·Status: UNKNOWN
-
Health Impact of Non-Tuberculous Mycobacteria Pulmonary Disease (NTM-PD)
NCT07192705 ·Status: RECRUITING
-
Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria
NCT03594032 ·Status: UNKNOWN
-
Outcome After Treatment of Pulmonary Aspergilloma
NCT01958710 ·Status: UNKNOWN
-
The Microbiome of Sputum, Urine and Feces in Healthy Persons and Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT03755505 ·Status: UNKNOWN
-
Markers of Pulmonary Dysbiosis Associated With Exacerbation in Patients Followed for Cystic Fibrosis
NCT03569904 ·Status: UNKNOWN
-
Interest of IgE Directed Against Recombinant Antigens of Aspergillus Fumigatus in the Diagnosis of Allergic Bronchopulmonary Aspergillosis (ABPA)
NCT07055230 ·Status: COMPLETED
-
Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study
NCT02058316 ·Status: COMPLETED
-
Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar Fluid
NCT04848831 ·Status: UNKNOWN
-
Pattern of Microbial Infection in AECOPD Patients and Its Sensitivity to Antibiotics
NCT06123780 ·Status: NOT_YET_RECRUITING
-
Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT00281242 ·Status: COMPLETED
-
Cytokine Profile of Allergic Bronchopulmonary Aspergillosis
NCT03643185 ·Status: UNKNOWN
-
Blood Fibrocytes During an Exacerbation and Lung Function Decline in Patients With COPD in Primary Care.
NCT04005833 ·Status: TERMINATED
-
Sputum Microbiota and the Association With Clinical Parameters in Steady-state, Acute Exacerbation and Convalescence of Bronchiectasis
NCT02315547 ·Status: UNKNOWN ·Phase: NA
-
A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE
NCT07245407 ·Status: RECRUITING
-
Risk of Aspergillus Infection in Patients With Chronic Lung Disease
NCT06379568 ·Status: COMPLETED
-
Fibrosing ILD Biomarkers That Rule Acceleration
NCT05635032 ·Status: RECRUITING